Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Patton is active.

Publication


Featured researches published by Robert Patton.


Bioorganic & Medicinal Chemistry Letters | 1996

A cembranolide diterpene farnesyl protein transferase inhibitor from the marine soft coral Lobophytum cristagalli

Stephen J. Coval; Robert Patton; Joanne M. Petrin; Linda James; Marnie L. Rothofsky; Stanley L. Lin; Mahesh Patel; John K. Reed; Andrew T. McPhail; W. Robert Bishop

Abstract A previously described cembranolide diterpene from Lobophytum cristagalli was identified as a potent (IC50 0.15 μM) inhibitor of farnesyl protein transferase (FPT). The compound showed selectivity for FPT as compared to the closely related enzyme geranylgeranyl protein transferase-1 (IC50 5.3 μM). Kinetic evaluation suggests that this compound competes with the protein/peptide farnesyl acceptor substrate, and not with farnesyl pyrophosphate for inhibition of FPT.


Tetrahedron Letters | 1995

SCH 58450, a novel farnesyl protein transferase inhibitor possessing a 6a,12a:7,12-diepoxybenz[a]anthracene ring system

David W. Phife; Robert Patton; Raymond Berrie; R. Yarborough; Mohindar S. Puar; Mahesh Patel; W. Robert Bishop; Stephen J. Coval

SCH 58450, a novel secondary metabolite possessing the 6a,12a:7,12.diepoxybenz[a]anthracene ring system, has been isolated from a Streptomyces sp. SCH 58450 inhibits farnesyl protein transferase with an IC50 of 29 μM, and shows 25 fold selectivity for farnesyl protein transferase over geranylgeranyl protein transferase-1.


Bioorganic & Medicinal Chemistry | 1999

Analogues of 1-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo-[5,6]-cyclohepta [1,2-b]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase.

Adriano Afonso; Jay Weinstein; Joseph M. Kelly; Ronald L. Wolin; Stuart B. Rosenblum; Michael Connolly; Timothy J. Guzi; Linda James; Donna Carr; Robert Patton; W. Robert Bishop; Paul Kirshmeier; Ming Liu; Larry Heimark; Kwang-jong Chen; Amin A. Nomeir

The synthesis of several 4-pyridylacetyl N-oxide derivatives of 4-(3-bromo-6,11-dihydro-5H-benzo[5,6]-cyclohepta[1,2-b]-pyridin-11-yl)pi perazine/piperidine 3 is described. This study was aimed at identifying fomesyl protein transferase (FPT) inhibitors in these two series of tricycles containing different phenyl ring substituents. The in vitro activity profile of the initial group of compounds 7a-7g led to the synthesis of the 8-methyl-10-methoxy and 8-methyl-10-bromo analogues 7i, 13i, and 13j. The 11R(-) enantiomers of these compounds were found to exhibit potent in vitro FPT inhibition activity.


Bioorganic & Medicinal Chemistry Letters | 2002

Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferase.

Alan B. Cooper; Corey Strickland; James Wang; Jagdish A. Desai; Paul Kirschmeier; Robert Patton; W. Robert Bishop; Patricia C. Weber; Viyyoor M. Girijavallabhan

A series of novel N-cyanoguanidine tricyclic farnesyl protein transferase (FPT) inhibitors was prepared. Replacement of a piperidine amide-group with a N-cyanoguanidine functionality increased FPT activity. X-ray crystal structure determination of 42 complexed with FPT revealed differences in the interactions of the amide and N-cyanoguanidine groups with the protein.


Bioorganic & Medicinal Chemistry Letters | 1997

Sch 207278: a novel farnesyl protein transferase inhibitor from an unidentified fungus

Min Chu; Ronald Mierzwa; Ellen Barrabee; Arthur King; Marc Hallade; Joseph Terracciano; Mahesh Patel; Robert Patton; W. Robert Bishop; Mohindar S. Puar

Abstract Novel aromatic dialdehyde, Sch 207278 (1), was isolated from an unidentified fungus as an inhibitor of farnesyl protein transferase (FPTase). The structure of 1 was elucidated by spectroscopic methods. Compound 1 exhibited an IC50 value of 3.5 μM against FPTase and 70 μM against geranylgeranyl protein transferase-1 (GGPTase-1), respectively.


Journal of Biological Chemistry | 1997

Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I

Fang L. Zhang; Paul Kirschmeier; Donna Carr; Linda James; Richard W. Bond; Lynn Wang; Robert Patton; William T. Windsor; Rosalinda Syto; Rumin Zhang; W. Robert Bishop


Journal of Biological Chemistry | 1995

Novel Tricyclic Inhibitors of Farnesyl Protein Transferase BIOCHEMICAL CHARACTERIZATION AND INHIBITION OF Ras MODIFICATION IN TRANSFECTED Cos CELLS

Bishop Wr; Richard W. Bond; Joanne M. Petrin; Lynn Wang; Robert Patton; Ronald J. Doll; Njoroge G; Joseph J. Catino; Schwartz J; William T. Windsor


Journal of Medicinal Chemistry | 1998

(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide (SCH-66336): A Very Potent Farnesyl Protein Transferase Inhibitor as a Novel Antitumor Agent

F. George Njoroge; Arthur G. Taveras; Joseph M. Kelly; Stacy W. Remiszewski; Alan K. Mallams; Ronald L. Wolin; Adriano Afonso; Alan B. Cooper; Dinananth F. Rane; Yi-Tsung Liu; Jesse Wong; Bancha Vibulbhan; Patrick A. Pinto; Jeffrey Deskus; Carmen Alvarez; Joycelyn del Rosario; Michael Connolly; James Wang; Jagdish A. Desai; Randall R. Rossman; W. Robert Bishop; Robert Patton; Lynn Wang; Paul Kirschmeier; Mathew S. Bryant; Amin A. Nomeir; Chuen-Horng Lin; Ming Liu; Andrew T. McPhail; Ronald J. Doll


Urologic Oncology-seminars and Original Investigations | 2005

A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer

Eric Winquist; Malcolm J. Moore; Kim N. Chi; D. Scott Ernst; Hal Hirte; Scott North; Jean Powers; Wendy Walsh; Therese Boucher; Robert Patton; Lesley Seymour


Journal of Medicinal Chemistry | 1997

Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine inhibitors of farnesyl-protein transferase : Design and synthesis of in vivo active antitumor compounds

Njoroge Fg; Bancha Vibulbhan; Rane Df; Bishop Wr; Joanne M. Petrin; Robert Patton; Mathew S. Bryant; Kwang-jong Chen; Amin A. Nomeir; Chin-Chung Lin; Ming Liu; King I; Jianping Chen; Suining Lee; Yaremko B; Janet Dell; Philip Lipari; Michael Malkowski; Zujun Li; Joseph J. Catino; Ronald J. Doll; Girijavallabhan; Ashit K. Ganguly

Collaboration


Dive into the Robert Patton's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge